The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of cataplexy or excessive ...

Southwest Research Institute (SwRI) and Trinity University are developing an intranasal (IN) drug-device combination to treat ...

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery ...

While many headline-grabbing biologics and advanced therapeutics like cell and gene therapies are approved as injectables, ...

Italian pharmaceutical company Cosmo Pharmaceuticals recently announced that its newly developed male-pattern hair loss ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

The fresh plea follows a recent court order allowing Dr. Reddy’s Laboratories (DRL) to continue manufacturing and exporting ...

Government ensures essential goods and medicines reflect GST reductions, with public awareness and grievance mechanisms in ...

Pfizer is rolling the dice again on an oral obesity pill. The pharmaceutical giant signed an exclusive global license agreement with YaoPharma, a subsidiary of China’s Fosun Pharma. The deal involves ...

Discover how creatine supplements may benefit perimenopausal women by enhancing muscle strength, mood, and cognitive function ...